# Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome

> **NCT06834594** · PHASE4 · RECRUITING · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 40 (estimated)

## Conditions studied

- Turner Syndrome
- Primary Ovarian Insufficiency (Poi)

## Interventions

- **DRUG:** Micronized progesterone 200 MG
- **DRUG:** Micronized Progesterone 100 MG

## Key facts

- **NCT ID:** NCT06834594
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06834594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06834594, "Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06834594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*